Trump pushes UN reform as world leaders gather for crisis talks

Agencies
September 18, 2017

United Nations, Sept 18: US President Donald Trump makes his debut at the United Nations on Monday, with an address on UN reform as a week of intense diplomacy kicks off, dominated by worries about North Korea, Iran and Myanmar.

Trump, who once disparaged the world body as a "club" for "people to get together, talk and have a good time," will lay out his views on how to improve the United Nations a day before he makes his first address to the General Assembly.

About 130 world leaders are attending this year's global gathering, but all eyes will be on Trump, whose "America First" agenda has alarmed both allies and foes.

The UN's number one financial backer, the United States has threatened deep cuts to UN funding that Secretary-General Antonio Guterres has said would create an "unsolvable problem" for the world body.

Guterres, who is pushing for an overhaul of the UN bureaucracy, will also address the event at which leaders will sign a pledge of support for reform.

France and Russia have reacted coolly to the US initiative, amid concerns that the US administration is focused more on cost-cutting than improving the UN's performance.

US Ambassador Nikki Haley was a driving force behind a $600-million-dollar cut to the UN peacekeeping budget this year.

Haley on Friday pointed to the more than 120 countries that back the US-drafted political declaration on UN reform as a "miraculous number," showing there is support for a "massive reform package" led by Guterres.

On Monday, Trump will hold talks with French President Emmanuel Macron, who will also be making his maiden address at the General Assembly on Tuesday, and with Israeli Prime Minister Benjamin Netanyahu.

Both Macron and Netanyahu are expected to raise the future of the Iran nuclear agreement, with the French leader making a strong case for keeping it alive and the Israeli prime minister pushing for its demise.

Trump will also have a working dinner with Latin American leaders that will touch on the crisis in Venezuela.

North Korea's nuclear and missile tests will be in the spotlight with foreign ministers set to discuss enforcing sanctions against Pyongyang during a Security Council meeting on non-proliferation on Thursday.

Also on Thursday, Trump will be holding talks with Japanese and South Korean leaders who have backed the US drive to ratchet up sanctions on North Korea.

The council last week imposed a new raft of measures such as a ban on export textiles and a cap on oil shipments to pile pressure on Pyongyang to come to the table and negotiate an end to its nuclear and missile programs.

Russia and China, however, are calling for diplomatic talks with North Korea while warning that a military option as suggested by the United States would have catastrophic consequences.

British Foreign Secretary Boris Johnson will host a meeting on the military campaign in Myanmar which the United Nations has described as "ethnic cleansing" after more than 400,000 Rohingya Muslims were forced to flee.

The closed-door meeting will be attended by a representative from Myanmar and by foreign ministers from "a range of countries with a strong interest in seeing an end to the violence there," a British diplomat said.

Ahead of the opening of the General Assembly, UN member-states will discuss the aftermath of Hurricane Irma that devastated parts of the United States and the Caribbean.

The hurricane disaster offers a reminder of the destructive force of nature as leaders set their sights on implementing the Paris agreement on climate change despite the US withdrawal from the deal.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 3,2020

Washington, Jun 3: US President Donald Trump's administration on Tuesday announced investigations into foreign digital services taxes it says are aimed squarely at American tech firms.

Following a similar trade investigation against France last year, the US Trade Representative office now is looking into taxes in Britain and the European Union, as well as Indonesia, Turkey and India.

"President Trump is concerned that many of our trading partners are adopting tax schemes designed to unfairly target our companies," USTR Robert Lighthizer said in a statement.

"We are prepared to take all appropriate action to defend our businesses and workers against any such discrimination."

Washington opposes the efforts to tax revenues from online sales and advertising, saying they single out US tech giants like Google, Apple, Facebook, Amazon and Netflix.

The US and France have agreed to negotiate till the end of the year over a digital services tax Paris approved in 2019, after USTR found them to be discriminating and threatened retaliatory duties of up to 100 percent on French imports such as champagne and camembert cheese.

Trump has embroiled the US in numerous trade disputes since taking office in 2017, including a months-long trade war with China that cooled with the signing of a partial deal in January.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 21,2020

Beijing, Mar 21: China reported no domestically transmitted coronavirus cases for the third consecutive day even as seven more fatalities have been confirmed, taking the death toll in the country to 3255.

No new domestically transmitted cases of COVID-19 were reported on the Chinese mainland for the third day in a row on Friday, China's National Health Commission (NHC) said on Saturday.

The overall confirmed cases on the mainland had reached 81,008 by the end of Friday, which included 3,255 who died, 6,013 patients still undergoing treatment, 71,740 patients who had been discharged after recovery, the NHC said.

The NHC said 41 new confirmed COVID-19 cases were reported on the Chinese mainland on Friday from the people arriving from abroad, taking the total number of imported cases to 269.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.